Search

Your search keyword '"Roncalli, M"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Roncalli, M" Remove constraint Author: "Roncalli, M" Database Unpaywall Remove constraint Database: Unpaywall
90 results on '"Roncalli, M"'

Search Results

2. Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases

6. TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers

11. Prognostic value of the immune-related transcriptome in biliary tract cancers

14. Correlation of metabolic information on 18F-FDG PET with the tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) candidate to upfront surgery

16. Cholangiocarcinoma Stem-Like Subset Shapes Tumor-Initiating Niche by Educating Associated Macrophages

18. Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs)

22. Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis

24. Reproducibility of the WHO classification of thymomas: Practical implications

28. P5-13-07: MET and Hepatocyte Growth Factor (HGF) Increased Gene Copy Number Is Associated to Trastuzumab Failure in HER2 Positive Metastatic Breast Cancer (MBC).

29. Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin

31. Prognostic role of nitrotyrosines in surgically resected non-small cell lung cancer (NSCLC).

38. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients

41. 9127 The role of thymidylate synthase (TS) and excision repair cross-complementing group 1 (ERCC1) immunohistochemical expression in malignant pleural mesothelioma patients treated with pemetrexed and carboplatin

44. 4 - The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

45. MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients

46. Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

47. Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

50. EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

Catalog

Books, media, physical & digital resources